On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells.
Neuro-Oncology
Stechishin, Owen D OD; Luchman, H Artee HA; Ruan, Yibing Y; Blough, Michael D MD; Nguyen, Stephanie A SA; Kelly, John J JJ; Cairncross, J Gregory JG; Weiss, Samuel S